These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 35163335)

  • 1. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
    Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
    Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
    Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress of therapeutic drugs for doxorubicin-induced cardiomyopathy.
    Chen Y; Shi S; Dai Y
    Biomed Pharmacother; 2022 Dec; 156():113903. PubMed ID: 36279722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
    Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
    Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
    Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model.
    Li X; Liang J; Qu L; Liu S; Qin A; Liu H; Wang T; Li W; Zou W
    Chem Biol Interact; 2022 Aug; 363():110008. PubMed ID: 35667395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
    Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
    Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX5A Alleviates Doxorubicin-Induced Cardiotoxicity by Suppressing Oxidative Stress, Mitochondrial Dysfunction and Cardiomyocyte Apoptosis.
    Zhang P; Lu H; Wu Y; Lu D; Li C; Yang X; Chen Z; Qian J; Ge J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice.
    Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H
    Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinnamaldehyde alleviates doxorubicin-induced cardiotoxicity by decreasing oxidative stress and ferroptosis in cardiomyocytes.
    Mao M; Zheng W; Deng B; Wang Y; Zhou D; Shen L; Niku W; Zhang N
    PLoS One; 2023; 18(10):e0292124. PubMed ID: 37824478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
    Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
    Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
    Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
    J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
    Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
    J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
    Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
    Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.
    Sun X; Sun P; Zhen D; Xu X; Yang L; Fu D; Wei C; Niu X; Tian J; Li H
    Toxicol Appl Pharmacol; 2022 Feb; 437():115902. PubMed ID: 35093381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner.
    Yang Y; Ren J; Zhang J; Shi H; Wang J; Yan Y
    Redox Biol; 2024 Apr; 70():103067. PubMed ID: 38316068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.